上市公司 Propanc Biopharma 计划收购 1 亿美元以太坊
ChainCatcher 消息，生物制药公司 Propanc Biopharma (纳斯达克股票代码: PPCB) 宣布计划在未来 12 个月内收购价值 1 亿美元的以太坊
该公司表示，此举将增强其在加密货币投资、药物开发和资产收购等多方面的企业战略
风险提示 风险提示
关联标签
关联标签
扫码下载
BTC $78,286.92 +2.99%
ETH $2,407.39 +4.35%
BNB $643.96 +1.98%
XRP $1.45 +1.25%
SOL $88.61 +3.68%
TRX $0.3328 +1.06%
DOGE $0.0976 +2.78%
ADA $0.2546 +2.42%
BCH $464.82 +4.67%
LINK $9.51 +1.30%
HYPE $41.31 +1.47%
AAVE $93.73 +2.35%
SUI $0.9680 +2.08%
XLM $0.1787 -0.31%
ZEC $320.80 -1.79% BTC $78,286.92 +2.99% ETH $2,407.39 +4.35% BNB $643.96 +1.98% XRP $1.45 +1.25% SOL $88.61 +3.68% TRX $0.3328 +1.06% DOGE $0.0976 +2.78% ADA $0.2546 +2.42% BCH $464.82 +4.67% LINK $9.51 +1.30% HYPE $41.31 +1.47% AAVE $93.73 +2.35% SUI $0.9680 +2.08% XLM $0.1787 -0.31% ZEC $320.80 -1.79%
风险提示 风险提示
ChainCatcher 与创新者共建Web3世界
